SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1

CUSIP: 84763AAB4

Q2 2017 13F Holders as of 30 Jun 2017

Type / Class
Debt / NOTE 2.750%12/1
Market price (% of par)
105.85%
Total 13F principal
$93,148,000
Principal change
+$31,000
Total reported market value
$98,061,651
Number of holders
14
Value change
+$94,988
Number of buys
5
Number of sells
5

Quarterly Holders Quick Answers

What is CUSIP 84763AAB4?
CUSIP 84763AAB4 identifies 84763AAB4 - SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 as of Q2 2017

As of 30 Jun 2017, SPECTRUM PHARMACEUTICALS INC - NOTE 2.750%12/1 was held by 14 institutional bondholders reporting positions in Form 13F filings. These institutions reported holding $93,148,000 in principal (par value) of the bond. The largest 10 bondholders included HIGHBRIDGE CAPITAL MANAGEMENT LLC, TENOR CAPITAL MANAGEMENT Co., L.P., CITADEL ADVISORS LLC, FMR LLC, SONORA INVESTMENT MANAGEMENT, LLC, WOLVERINE ASSET MANAGEMENT LLC, OAKTREE CAPITAL MANAGEMENT LP, Context Capital Management, LLC, ASHFORD CAPITAL MANAGEMENT INC, and Bank of New York Mellon Corp. This page lists 14 institutional bondholders reporting positions for the Q2 2017 filing period.
Investor Option Weight % Change % Value $ * Price (% of par) Principal Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.